Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Renea A Taylor

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
The Journal of Pathology|April 5, 2024
Co-targeting BET, CBP, and p300 inhibits neuroendocrine signalling in androgen receptor-null prostate cancerNicholas Choo, Shivakumar Keerthikumar, Susanne Ramm, et al.
Clinical Epigenetics|March 20, 2020
Alterations in the methylome of the stromal tumour microenvironment signal the presence and severity of prostate cancerMitchell G Lawrence, Ruth Pidsley, Birunthi Niranjan, et al.
The Prostate|July 17, 2015
Establishment of primary patient-derived xenografts of palliative TURP specimens to study castrate-resistant prostate cancerMitchell G Lawrence, David W Pook, Hong Wang, et al.
Nature Protocols|April 6, 2013
A preclinical xenograft model of prostate cancer using human tumorsMitchell G Lawrence, Renea A Taylor, Roxanne Toivanen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 11, 2012
Evidence for efficacy of new Hsp90 inhibitors revealed by ex vivo culture of human prostate tumorsMargaret M Centenera, Joanna L Gillis, Adrienne R Hanson, et al.
European Urology|August 27, 2014
Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor prognosisGail P Risbridger, Renea A Taylor, David Clouston, et al.
Oncotarget|December 2, 2014
Estrogen receptor alpha drives proliferation in PTEN-deficient prostate carcinoma by stimulating survival signaling, MYC expression and altering glucose sensitivityItsuhiro Takizawa, Mitchell G Lawrence, Preetika Balanathan, et al.
SLAS Discovery : Advancing Life Sciences R & D|June 11, 2021
High-Throughput Imaging Assay for Drug Screening of 3D Prostate Cancer OrganoidsNicholas Choo, Susanne Ramm, Jennii Luu, et al.
Neoplasia (New York, N.Y.)|March 23, 2019
Characterization of the ERG-regulated Kinome in Prostate Cancer Identifies TNIK as a Potential Therapeutic TargetRachel S Lee, Luxi Zhang, Adeline Berger, et al.
Cancers|April 3, 2021
Mast Cell-Derived SAMD14 Is a Novel Regulator of the Human Prostate Tumor MicroenvironmentLinda K H Teng, Brooke A Pereira, Shivakumar Keerthikumar, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
The Journal of Pathology|April 5, 2024
Co-targeting BET, CBP, and p300 inhibits neuroendocrine signalling in androgen receptor-null prostate cancerNicholas Choo, Shivakumar Keerthikumar, Susanne Ramm, et al.
Clinical Epigenetics|March 20, 2020
Alterations in the methylome of the stromal tumour microenvironment signal the presence and severity of prostate cancerMitchell G Lawrence, Ruth Pidsley, Birunthi Niranjan, et al.
The Prostate|July 17, 2015
Establishment of primary patient-derived xenografts of palliative TURP specimens to study castrate-resistant prostate cancerMitchell G Lawrence, David W Pook, Hong Wang, et al.
Nature Protocols|April 6, 2013
A preclinical xenograft model of prostate cancer using human tumorsMitchell G Lawrence, Renea A Taylor, Roxanne Toivanen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 11, 2012
Evidence for efficacy of new Hsp90 inhibitors revealed by ex vivo culture of human prostate tumorsMargaret M Centenera, Joanna L Gillis, Adrienne R Hanson, et al.
European Urology|August 27, 2014
Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor prognosisGail P Risbridger, Renea A Taylor, David Clouston, et al.
Oncotarget|December 2, 2014
Estrogen receptor alpha drives proliferation in PTEN-deficient prostate carcinoma by stimulating survival signaling, MYC expression and altering glucose sensitivityItsuhiro Takizawa, Mitchell G Lawrence, Preetika Balanathan, et al.
SLAS Discovery : Advancing Life Sciences R & D|June 11, 2021
High-Throughput Imaging Assay for Drug Screening of 3D Prostate Cancer OrganoidsNicholas Choo, Susanne Ramm, Jennii Luu, et al.
Neoplasia (New York, N.Y.)|March 23, 2019
Characterization of the ERG-regulated Kinome in Prostate Cancer Identifies TNIK as a Potential Therapeutic TargetRachel S Lee, Luxi Zhang, Adeline Berger, et al.
Cancers|April 3, 2021
Mast Cell-Derived SAMD14 Is a Novel Regulator of the Human Prostate Tumor MicroenvironmentLinda K H Teng, Brooke A Pereira, Shivakumar Keerthikumar, et al.
Pageof 9